FDA Inspection
Scinopharm Taiwan LtdScinopharm Taiwan Ltd – FDA Inspection, May 17, 2019
Record Details
This FDA Inspection record concerns Scinopharm Taiwan Ltd, with an inspection on May 17, 2019, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · 7044bf7c-e911-4e7c-84ce-056f5f8b6169
Inspection Facts
No Action Indicated (NAI)
No objectionable conditions or practices were found during the inspection.
- Inspection number
- 1094253
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
Other FDA inspections of Scinopharm Taiwan Ltd
7| Date | Classification | Office | Project area |
|---|---|---|---|
| June 23, 2026 | Not classified | Office of Inspections and Investigations | Drug Quality Assurance |
| March 21, 2024 | NAI | Center for Devices and Radiological Health | Compliance: Devices |
| October 25, 2022 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| February 10, 2017 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| March 27, 2015 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Scinopharm Taiwan Ltd
- FDA Inspection 1326554 - 2026-06-23
- FDA Inspection 1235581 - 2024-03-21
- FDA Inspection 1191835 - 2022-10-25
- FDA Inspection 1004952 - 2017-02-10
- FDA Inspection 921134 - 2015-03-27
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.